AAN 2023: Rozanolixizumab yields benefits across gMG patient groups

AAN 2023: Rozanolixizumab yields benefits across gMG patient groups

People with generalized myasthenia gravis (gMG) treated with the experimental therapy rozanolixizumab in a clinical trial generally experienced reductions in disease severity scores regardless of disease duration, prior treatments, and initial disease severity, new analyses suggest. Findings were presented by Tuan Vu, MD, of the University of South…

AAN 2023: Vyvgart for 2 years seen to ease symptoms of gMG in study

Treatment with Vyvgart (efgartigimod alfa-fcab) over two years was found to safely and effectively ease symptoms of generalized myasthenia gravis (gMG) among participants in an open-label extension study, according to an analysis of new data. “This analysis suggests that long-term efgartigimod [Vyvgart] treatment is well tolerated and…

AAN 2023: Zilucoplan eases symptoms in all subgroups in trial

Treatment with the experimental therapy zilucoplan eased symptoms of generalized myasthenia gravis (gMG) across different subgroups of patients participating in the Phase 3 RAISE clinical trial. Trial data showed treatment effects were consistent, regardless of sex, age, disease duration, prior use of certain treatments, or thymoma status. Findings…

What myasthenia gravis taught me about being a business owner

The COVID-19 lockdowns had just started, and small businesses around the world were shuttering at an alarming rate. Many weren’t only temporarily adjusting, they were closing for good. Being in quarantine meant no customers wandering around downtown to shop on a lazy Sunday afternoon. There were no lunchtime meetings,…

Overcoming the shame of prednisone-induced weight gain

Note: This column describes the author’s own experiences with prednisone. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. Living with myasthenia gravis (MG), or any rare disease, brings physical and emotional challenges. Since my diagnosis in 2020,…

Robot-assisted thymectomy ‘safe and feasible’ in MG: Study

Robot-assisted surgery to remove the thymus is generally safe for people with myasthenia gravis (MG), with most patients who undergo the procedure seeing a reduction in symptom severity afterward, a study reports. “This retrospective follow-up study showed that robotic thymectomy [thymus removal surgery] is safe and feasible in patients…